CYTOKINE PRODUCTION IN RA SYNOVIAL TISSUE AFTER MUCOSAL TOLERIZATION
CYTOKINE PRODUCTION IN RA SYNOVIAL TISSUE AFTER MUCOSAL TOLERIZATION
批准号:
6310394
负责人:
Salvatore Albani
金额:
$11.25万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 2001-02-28
中文摘要
在促使这项拨款申请的初步实验中,我们已经表明:i)细菌来源的肽(E。coli dna J热休克蛋白)是类风湿性关节炎(RA)患者中促炎性T细胞应答的靶标。dnaJ与HLA DRB 1 *0401共享对RA的易感性序列(共享表位)。基于这些初步结果,我们提出dnaJ作为可能的抗原之一,这可能有助于RA中慢性自身免疫性炎症的产生; ii)使用新的技术方法,可以鉴定、分离和表征RA患者血液中与共享表位反应的T细胞(T细胞捕获:TCC),这是我们已经开发的; iii)我们已经鉴定了一种dnaJ衍生肽(dnaJP 1),其已经在旨在调节RA中的这些促炎反应的临床试验的I期中成功地测试。该提议与RA中对dnaJPl的炎症反应的调节的试验性II期、双盲、安慰剂对照试验有关。我们将在该研究中通过临床和免疫学结果测量来评估免疫调节治疗的功效。我们将扩展该分析以研究治疗对抗原特异性T细胞的影响,以便也识别疾病活动和治疗功效的替代标记物。审判定于2000年2月开始。上述项目虽然提供了对免疫调节治疗在RA患者中诱导的免疫变化的综合分析,但在评价炎症滑膜部位治疗诱导的表型和功能变化方面仍有福尔斯不足。在这里,我们建议纵向分析这种变化的滑膜活检样本中获得的队列患者参加了在UCSD网站的试验。将进行样品的细胞因子生产,并与从II期项目中获得的免疫学和临床数据相关联。该项目的具体目标是:(1)在基线和治疗结束(6个月持续时间)时收集II期试验入组患者的滑膜活检标本;(2)建立适用于分子生物学、免疫学和组织学研究的样本库;(3)通过实时PCR(TaqMan)提取和评价促炎性和致耐受性细胞因子的产生和趋化因子受体表达
英文摘要
In preliminary experiments that prompted this grant application, we have shown that: i) peptides of bacterial origin (E. coli dnaJ heat shock protein) are a target of pro-inflammatory T cell responses in rheumatoid arthritis (RA) patients. dnaJ shares with HLA DRBI*0401 the susceptibility sequence to RA (shared epitope). Based upon these initial results, we have proposed dnaJ as one of the possible antigens, which may contribute to the generation of chronic autoimmune inflammation in RA; ii) T cells in the blood of RA patients that react with the shared epitope can be identified, isolated and characterized, using a novel technical approach (T cell capture: TCC), which we have developed; iii) We have identified a dnaJ-derived peptide (dnaJP1) which has been successfully tested in Phase I of a clinical trial aimed at modulating these pro-inflammatory responses in RA. This proposal is connected to a pilot Phase II, double blind, placebo controlled trial of modulation of inflammatory responses to dnaJPl in RA. We will evaluate in that study efficacy of immunomodulatory treatment by clinical and immunological outcome measurements. We will extend this analysis to study the effect of the treatment on antigen-specific T cells, in order also to identify surrogate markers for disease activity and treatment efficacy. The trial is due to start in February 2000. The above mentioned project, while providing a comprehensive analysis of immune changes induced in RA patients by an immunomodulatory treatment, still falls short in evaluating phenotypical and functional changes induced by the treatment at synovial sites of inflammation. Here, we propose to analyze such changes longitudinally in synovial biopsies samples obtained from the cohort of patients enrolled in the trial at the UCSD site. Cytokine production of the samples will be performed, and correlated with immunological and clinical data obtained from the Phase II project. The specific aims for this project are: (1) To collect synovial biopsies from patients enrolled in the Phase II trial at baseline and end-treatment (six months duration) points; (2) to establish a library of samples suitable for molecular biology, immunology and histology studies; and (3) to extract evaluate production of pro-inflammatory and tolerogenic cytokines and chemokine receptors expression by real-time PCR (TaqMan)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Immune Modulation in JIA
-
批准号:8116195
-
项目类别:
-
资助金额:$43.22万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Immune tolerance in the therapy of rheumatoid arthritis
-
批准号:8052528
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Mechanisms of Immune Modulation in JIA
-
批准号:8319525
-
项目类别:
-
资助金额:$40.07万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Mechanisms of Immune Modulation in JIA
-
批准号:7668315
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Immune tolerance in the therapy of rheumatoid arthritis
-
批准号:7912931
-
项目类别:
-
资助金额:$38.2万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Mechanisms of Immune Modulation in JIA
-
批准号:7937821
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Mechanisms of Immune Modulation in JIA
-
批准号:8131841
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Mechanisms of Immune Modulation in JIA
-
批准号:8529190
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
Immune tolerance in the therapy of rheumatoid arthritis
-
批准号:7756214
-
项目类别:
-
资助金额:$3.53万
-
财政年份:2009
-
负责人:Salvatore Albani
-
依托单位:
MODULATION OF IMMUNE SYNAPSE BY ENGINEERED AAPC
-
批准号:7358022
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2006
-
负责人:Salvatore Albani
-
依托单位:
MODULATION OF IMMUNE SYNAPSE BY ENGINEERED AAPC
-
批准号:7181317
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2005
-
负责人:Salvatore Albani
-
依托单位:
MODULATION OF IMMUNE SYNAPSE BY ENGINEERED AAPC
-
批准号:6975338
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2004
-
负责人:Salvatore Albani
-
依托单位:
Innate and adaptive Treg in Immune tolerization of RA
-
批准号:6781373
-
项目类别:
-
资助金额:$23.04万
-
财政年份:2004
-
负责人:Salvatore Albani
-
依托单位:
Innate and adaptive Treg in Immune tolerization of RA
-
批准号:6948600
-
项目类别:
-
资助金额:$23.11万
-
财政年份:2004
-
负责人:Salvatore Albani
-
依托单位:
Clinical Trial of Epitope Peptides in RA
-
批准号:7045379
-
项目类别:
-
资助金额:$0.71万
-
财政年份:2003
-
负责人:Salvatore Albani
-
依托单位:
CLINICAL TRIAL OF EPITOPE PEPTIDES IN RHEUMATOID ARTHRITIS
-
批准号:7205560
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2003
-
负责人:Salvatore Albani
-
依托单位:
海外基金